NO20030648L - Perfluoralkylholdige komplekser inneholdende sukkerresiduer, fremgangsmåtefor fremstilling av det samme og anvendelse derav - Google Patents

Perfluoralkylholdige komplekser inneholdende sukkerresiduer, fremgangsmåtefor fremstilling av det samme og anvendelse derav

Info

Publication number
NO20030648L
NO20030648L NO20030648A NO20030648A NO20030648L NO 20030648 L NO20030648 L NO 20030648L NO 20030648 A NO20030648 A NO 20030648A NO 20030648 A NO20030648 A NO 20030648A NO 20030648 L NO20030648 L NO 20030648L
Authority
NO
Norway
Prior art keywords
perfluoroalkyl
preparing
same
sugar residues
complexes containing
Prior art date
Application number
NO20030648A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030648D0 (no
Inventor
Johannes Platzek
Peter Mareski
Ulrich Niedballa
Bernd Raduechel
Hanns-Joachim Weinmann
Bernd Misselwitz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20030648D0 publication Critical patent/NO20030648D0/no
Publication of NO20030648L publication Critical patent/NO20030648L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20030648A 2000-08-11 2003-02-10 Perfluoralkylholdige komplekser inneholdende sukkerresiduer, fremgangsmåtefor fremstilling av det samme og anvendelse derav NO20030648L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10040381A DE10040381C1 (de) 2000-08-11 2000-08-11 Perfluoralkylhaltige Komplexe mit Zuckerresten, Verfahren zu deren Herstellung und ihre Verwendung
PCT/EP2001/008499 WO2002014309A1 (fr) 2000-08-11 2001-07-23 Complexes perfluoroalkyles a residus saccharides, leur procede de fabrication et leur utilisation

Publications (2)

Publication Number Publication Date
NO20030648D0 NO20030648D0 (no) 2003-02-10
NO20030648L true NO20030648L (no) 2003-04-11

Family

ID=7652861

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030648A NO20030648L (no) 2000-08-11 2003-02-10 Perfluoralkylholdige komplekser inneholdende sukkerresiduer, fremgangsmåtefor fremstilling av det samme og anvendelse derav

Country Status (31)

Country Link
EP (1) EP1307446B1 (fr)
JP (1) JP2004506631A (fr)
KR (1) KR100820387B1 (fr)
CN (1) CN1249058C (fr)
AR (1) AR035579A1 (fr)
AT (1) ATE293623T1 (fr)
AU (2) AU2001289729B2 (fr)
BG (1) BG107540A (fr)
BR (1) BR0113192A (fr)
CA (1) CA2418790A1 (fr)
CZ (1) CZ2003340A3 (fr)
DE (2) DE10040381C1 (fr)
DK (1) DK1307446T3 (fr)
EE (1) EE200300059A (fr)
ES (1) ES2240517T3 (fr)
HK (1) HK1062016A1 (fr)
HR (1) HRP20030172A2 (fr)
HU (1) HUP0300744A3 (fr)
IL (1) IL154328A0 (fr)
MX (1) MXPA03001285A (fr)
NO (1) NO20030648L (fr)
NZ (1) NZ524079A (fr)
PL (1) PL360359A1 (fr)
PT (1) PT1307446E (fr)
RU (1) RU2280644C2 (fr)
SK (1) SK1542003A3 (fr)
TW (1) TWI243170B (fr)
UA (1) UA75364C2 (fr)
WO (1) WO2002014309A1 (fr)
YU (1) YU10403A (fr)
ZA (1) ZA200301948B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19948651B4 (de) * 1999-09-29 2006-10-05 Schering Ag Para- und diamagnetische perfluorhaltige Verbindungen enthaltende galenische Formulierungen, deren Herstellung und Verwendung
US7344704B2 (en) 2002-07-10 2008-03-18 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi
DE10231799B4 (de) * 2002-07-10 2006-10-05 Schering Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Intravasalen Thromben
DE10260372B4 (de) 2002-12-13 2007-01-04 Schering Ag Kernspintomographievorrichtung und Verfahren zur ortsaufgelösten Bilddarstellung
JP2009509915A (ja) * 2005-07-15 2009-03-12 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト ペルフルオロアルキル含有錯体、ならびにｎｍｒ、ｘ線および放射線診断、さらに放射線治療のための造影剤としてのその使用法
DE102006049821A1 (de) 2006-10-18 2008-04-24 Bayer Schering Pharma Aktiengesellschaft Metallchelate mit perfluoriertem PEG-Rest, Verfahren zu deren Herstellung, sowie deren Verwendung
US20100215581A1 (en) * 2006-10-25 2010-08-26 Koninklijke Philips Electronics N.V. Contrast agents for detecting prostate cancer
DE102008024976A1 (de) 2008-05-23 2009-12-17 Marvis Technologies Gmbh Medizinisches Instrument
JP2011190183A (ja) * 2010-03-11 2011-09-29 Noguchi Institute フルオラス化糖結合型クラウンエーテル誘導体
EP2450067A1 (fr) 2010-10-18 2012-05-09 MaRVis Technologies GmbH Dispositif médical
EP2484388A1 (fr) 2011-02-05 2012-08-08 MaRVis Technologies GmbH Dispositif médical implantable ou insérable détectable par IRM doté d'un revêtement comportant des ions paramagnétiques et son procédé de préparation
EP2692365A1 (fr) 2012-08-03 2014-02-05 MaRVis Medical GmbH Dispositif médical implantable ou insérable détectable par IRM doté dýun revêtement comportant des ions paramagnétiques et son procédé de préparation
EP3101012A1 (fr) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft Nouveaux composés de chélate de gadolinium pour une utilisation dans l'imagerie par résonance magnétique
CA3044877A1 (fr) 2016-11-28 2018-05-31 Bayer Pharma Aktiengesellschaft Composes de chelate de gadolinium a relaxivite elevee pour utilisation dans l'imagerie par resonance magnetique
EP3883613A1 (fr) 2018-11-23 2021-09-29 Bayer Aktiengesellschaft Formulation de milieux de contraste et procédé de préparation associé

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707604A (en) * 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
AU623901B2 (en) * 1988-01-26 1992-05-28 Nycomed As Paramagnetic compounds comprising chelating moiety, linker group macro molecule and paramagnetic metal
CA2069886A1 (fr) * 1989-10-23 1991-04-24 David Love Agents de chelation de metaux a sites multiples
US5330743A (en) * 1992-11-12 1994-07-19 Magnetic Research, Inc. Aminosaccharide contrast agents for magnetic resonance images
IL115670A (en) * 1994-10-21 1999-11-30 Nihon Mediphysics Co Ltd Diagnostic imaging agent
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19728954C1 (de) * 1997-06-30 1999-04-22 Schering Ag Saccharid-Konjugate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19729013A1 (de) * 1997-07-03 1999-02-04 Schering Ag Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19744004C1 (de) * 1997-09-26 1999-07-22 Schering Ag Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging
DE19758105A1 (de) * 1997-12-18 1999-06-24 Schering Ag Dendritische Polymer-Saccharid-Konjugate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19914101C1 (de) * 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
DE19948651B4 (de) * 1999-09-29 2006-10-05 Schering Ag Para- und diamagnetische perfluorhaltige Verbindungen enthaltende galenische Formulierungen, deren Herstellung und Verwendung

Also Published As

Publication number Publication date
NO20030648D0 (no) 2003-02-10
HUP0300744A3 (en) 2009-01-28
EP1307446B1 (fr) 2005-04-20
PL360359A1 (en) 2004-09-06
CN1249058C (zh) 2006-04-05
CA2418790A1 (fr) 2003-02-07
WO2002014309A1 (fr) 2002-02-21
SK1542003A3 (en) 2003-10-07
AU8972901A (en) 2002-02-25
RU2280644C2 (ru) 2006-07-27
ATE293623T1 (de) 2005-05-15
BG107540A (bg) 2003-11-28
IL154328A0 (en) 2003-09-17
JP2004506631A (ja) 2004-03-04
CN1468234A (zh) 2004-01-14
EE200300059A (et) 2004-12-15
HRP20030172A2 (en) 2005-04-30
ES2240517T3 (es) 2005-10-16
DE50105965D1 (de) 2005-05-25
CZ2003340A3 (cs) 2003-09-17
BR0113192A (pt) 2003-07-15
YU10403A (sh) 2006-05-25
HUP0300744A2 (hu) 2003-09-29
AU2001289729B2 (en) 2006-11-16
AR035579A1 (es) 2004-06-16
HK1062016A1 (en) 2004-10-15
DE10040381C1 (de) 2002-06-06
KR20030024855A (ko) 2003-03-26
KR100820387B1 (ko) 2008-04-08
UA75364C2 (en) 2006-04-17
ZA200301948B (en) 2004-06-25
NZ524079A (en) 2005-10-28
MXPA03001285A (es) 2004-05-17
TWI243170B (en) 2005-11-11
DK1307446T3 (da) 2005-08-15
PT1307446E (pt) 2005-08-31
EP1307446A1 (fr) 2003-05-07

Similar Documents

Publication Publication Date Title
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
TWI315741B (en) A-isomaltosyltransferase, process for producing the same and use thereof
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
NO20024281D0 (no) Indolderivater, fremgangsmåte for fremstilling av de samme og anvendelse derav
HUP0402264A3 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines process for preparing them, pharmaceutical compositions containing them and use thereof
ZA200210411B (en) Novel heteroaryl derivatives and the use thereof as pharmaceuticals.
ZA200210180B (en) Novel heteroaryl derivatives and the use thereof as pharmaceuticals.
MXPA03000873A (es) Derivados de quinazolina, medicamentos que contienen estos compuestos, su uso y metodos para la produccion de los mismos.
NO20013803D0 (no) Polymert adsorpsjonsmiddel og fremgangsmåte til fremstilling av samme
NO20030648L (no) Perfluoralkylholdige komplekser inneholdende sukkerresiduer, fremgangsmåtefor fremstilling av det samme og anvendelse derav
NO20030800L (no) Aminoalkylbenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte forderes fremstilling og preparater inneholdende de samme
DK1261697T3 (da) Kuldeaktiv beta-galactosidase, fremgangsmåde til fremstilling heraf og anvendelsen deraf
ZA200300743B (en) DDS compound and process for the preparation thereof.
AU2001289729A1 (en) Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof
EE200300060A (et) Polaarsete rühmadega perfluoroalküülrühma sisaldavad kompleksid, nende valmistamismeetod ja kasutamine
AU2001242795A1 (en) Condensed pyrazole derivatives, process for producing the same and use thereof
MXPA03006249A (es) Derivados de 2-arilimino-2,3-dihidrotiazoles, sus procesos de preparacion y su uso terapeutico.
IL156162A0 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof.
EP1273657A4 (fr) Nouvelle proteine, son procede de production et d'utilisation
MXPA03007550A (es) Derivados coloporosidos, proceso para su preparacion y su uso.
EP1415983A4 (fr) Derive de 5-amidino-n-(2-aminophenethyl)-n- hydroxybenzensulfonamide, composition medicinale le contenant et intermediaire utilise
IL159561A0 (en) Eurotinones and derivatives thereof, processes for preparing them, and their use
HK1052709A1 (en) Pluraflavins and derivatives thereof, process for their preparation and use thereof pluraflavin.
EP1331269A4 (fr) Nouvelle proteine, son procede de production et son utilisation
MXPA03008636A (es) Derivados de isoquinuclidina, metodo para fabricar los mismos y agentes terapeuticos que contienen estos compuestos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application